Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection

Indian Journal of Medical Research

Volumn 123, Issue 3, 2006, Pages 197-202

  Sinha, P K ^a   Bimal, Sanjiva ^a   Singh, S K ^a   Pandey, Krishna ^a   Gangopadhyay, D N ^a   Bhattacharya, S K ^b  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Direct agglutination test; Gama interferon; HIV; Interleukin 4; Visceral leishmaniasis

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ADOLESCENT; ADULT; AGGLUTINATION TEST; ARTICLE; BONE MARROW BIOPSY; CELLULAR IMMUNITY; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; HEALTH CARE FACILITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; INDIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PARASITE IDENTIFICATION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; SENSITIVITY ANALYSIS; SEROLOGY; SPLEEN BIOPSY; SUPERINFECTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INDIA; INFANT; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; SPLEEN;

EID: 33745207332     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hailu A, Berhe N. The performance of Direct Agglutination Test (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV co-infection. Ann Trop Med Parasitol 2002; 96: 25-30.
2. Berhe N, Hailu A, Walday D, Negesse Y, Cenini P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with human immuno deficiency virus. Trans R Soc Trop Med Hyg 1995; 89: 205-7.
3. Desjeux P UNAIDS. Leishmania and HIV in Gridlok-Document WHO/CTD/LEISH/ 98.9 Add. 1, UNAIDS/98.23. Geneva: World Health Organization; 1998.
4. Sinha PK, Das VNR, Pandey K, Ranjan A, Birnal S, Singh V, et al. Evaluation of clinico-pathological features in Indian kala-azar patients with HIV co-infection in relation to amphotericin-B treatment. Proc: WHO workshop on strategies for control of kala-azar and malaria, Balaji Uthan Sansthan, Patna, 27-28 December, 2001; 123-7.
5. Thakur CP, Sinha PK, Singh RK, Hassan SM, Narayan S. Miltefosine in a case of visceral leishmaniasis with HIV co-infection and rising incidence of this disease in India. Trans R Soc Trop Med Hyg 2000; 94 : 696-7.
6. Mukhopadhyay C, Nath G, Gulati AK, Mohapatra SC. Prevalence of HIV among low and high risk population of eastern part of northen India. J Commun Dis 2000; 33 : 136-42.
7. Chulay JD, Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splinic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983; 32 : 475-9.
8. Harith A, Kolk AH, Muigai R, Huigem E, Jelsma T, Kager PA. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol 1988; 26 : 1321-5.
9. Morenso J, Canavate C, Chamizo C, Laguna F, Alvar J. HIV-Leishmania co-infection: Humoral and cellular immune responses to the parasite after chemotherapy. Trans R Soc Trop Med Hyg 2000; 94 : 328-32.
10. Sharma MC, Bimal S, Ranjan A, Das VNR, Gupta AK, Kumar N, et al. Relevance of DAT in sero-epidemiological survey of kala-azar in epidemic foci of Bihar. J Commun Dis 2000; 32 : 117-22.
11. Nigro L, Vinci C, Romano F, Russo R. Comparison of the indirect immunofluorescent antibody test and the direct agglutination test for sero-diagnosis of VL in HIV infected subjects. Eur J Clin Microbiol Infect Dis 1996; 15 : 832-5.
12. Pintado V, Martin-Rabadan P, Rivera ML, Moreno S, Bouza E. Visceral leishmaniasis in human immunodeficiency virus (HIV infected and non-HIV infected patients): A comparative study. Medicine 2001; 80 : 54-73.
13. Medrano FJ, Canavate C, Leal M, Rey C, Lissen E, Alvar J. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients co-infected with HIV type 1. Am J Trop Med Hyg 1998; 59 : 155-62.
14. Santos-Gomes G, Gomes-Pereiras, Campino L, Araujo MD, Abranches P. Performance of immunobloting in diagnosis of VL in human immunodeficiency virus-Leishmania sp. co-infected patients. J Clin Microbiol 2000; 38 : 175-8.
15. Lehmann JK, Eussle KH, Lehman I, Emmendorf A, Lohman-Mathes ML. The capacity to produce IFN-γ rather than the presence of IL4 determines resistance and degree of susceptibility to Leishmania donovani infection in mice. J Interferon Cytokine Res 2000; 20 : 63-77.
16. Ghosh MK, Nandi A, Addy M, Maitra TK, Ghosh AC. Subpopulations of T-lymphocytes in the peripheral blood, dermal lesions and lymph nodes of post kala-azar dermal leishmaniasis patients. Scand J Immunol 1995; 41 : 11-7.
17. Miralles GD, Stocckle MY, McDerrmott DF, Finkelman FD, Murray HW. Induction of Th1 and Th2 cell associated cytokines in experimental visceral leishmaniasis. Infect Immun 1994; 62 : 1058-63.
18. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Ann Rev Immunol 1995; 13 : 151-77.
19. Sunder, S, Reed GS, Sharma S, Mehrotra A, Murray HW. Circulating T-helper1 (Th1) cell and Th2 cell associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997; 56 : 522-35.
20. Thakur CP, Mitra DK, Narayan S. Skewing of cytokine profiles towards T-helper cell type2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Tran Trop Med Hyg 2003; 97 : 409-12.
21. Mayanja-Kizza H, Johnson JL, Hirsch CS, Peters P, Surewicz K, Wu M, et al. Macrophage activating cytokines in human immunodeficiency virus type 1 infected and uninfected patients with pulmonary tuberculosis. J Infect Dis 2001; 183 : 1805-9.
22. Oliveira-Pinto LM, Garcia S, Lecoeur H, Rapp C, Gougeon ML. Increased sensitivity of T-lymphocytes to tumor necrosis factor receptor one (TNF-R1 and TNF R2 mediated apoptosis in HIV infection: Relation to expression of BCL-2 and active caspase-8 and caspase-3. Blood 2002; 99 : 1666-75.